Fmoc-L-Leu-OSu

Fmoc-L-Leu-OSu is an Fmoc-protected L-leucine N-(9H-fluoren-9-ylmethoxycarbonyl) amino acid activated as an N-hydroxysuccinimide ester (OSu). The molecule retains the leucine stereocenter in the S configuration and presents a side-chain isobutyl group that supports hydrophobic peptide microenvironments and fragment-based binding motifs. The Fmoc carbamate enables standard base-labile protection management during solid-phase peptide synthesis, while the OSu ester introduces an acylating functionality that can react with nucleophiles such as amines under peptide-coupling compatible conditions. This combination makes Fmoc-L-Leu-OSu a chiral, protected amino acid derivative suitable for preparing peptide building blocks, amide-linked conjugates, and downstream intermediates for synthetic and biochemical workflows.

1. Peptide Synthesis

Fmoc-L-Leu-OSu supports peptide building block preparation for both manual and automated peptide synthesis workflows by pairing Fmoc N-protection with an activated OSu ester for rapid amide bond formation. The leucine backbone and stereochemical integrity allow incorporation of L-leucine residues into peptide sequences while maintaining predictable coupling geometry and side-chain hydrophobicity. The OSu leaving group can facilitate nucleophilic acyl substitution with peptide-forming amines, and subsequent Fmoc deprotection can regenerate the reactive N-terminus for iterative chain elongation. Downstream peptide analog construction benefits from the compatibility of this activated amino acid with protected-amino acid strategies and standard peptide assembly logic.

2. Bioconjugation Chemistry

Fmoc-L-Leu-OSu can be used in chemical biology and bioconjugation settings to generate leucine-containing amide linkages through OSu-mediated acylation of primary amines. The activated ester functionality enables coupling to amino groups present on peptides, protein lysine residues, or amine-bearing linkers, while the Fmoc group provides an orthogonal handle for controlled deprotection and subsequent coupling steps. The preserved L-leucine stereochemistry and hydrophobic side chain can influence conjugate conformation and local microenvironment in linker regions. Resulting leucine-amide conjugates can serve as materials for biomolecule labeling, reagent synthesis, and structure-defined probe generation in applied biochemical research.

3. Side-Chain Functionalization

Fmoc-L-Leu-OSu is suitable for side-chain functionalization and intermediate construction where leucine-derived amide formation is required as a synthetic junction. The N-Fmoc protected amino acid framework can be managed to control when the amino functionality becomes available, supporting sequential derivatization schedules in multistep syntheses. The OSu ester enables attachment to nucleophiles that carry functional groups for subsequent transformations, including linker installation for peptidomimetic scaffolds or attachment of reporter-bearing amines. Downstream products can be converted into further protected amino acid derivatives or used as defined fragments in medicinal chemistry and materials-oriented synthesis.

4. Pharmaceutical Intermediate Preparation

Fmoc-L-Leu-OSu fits pharmaceutical intermediate preparation workflows that require chiral, protected amino acid derivatives for controlled amide bond formation during fine chemical synthesis. The Fmoc-protected N-terminus supports orthogonal protection strategies common to peptide-like and peptidomimetic intermediates, while the OSu activation provides a practical route to couple leucine units to amine-containing partners. The leucine side chain contributes hydrophobic character that can be leveraged in fragment assembly and in the construction of stereochemically defined building blocks for process chemistry. Industrially relevant downstream utility includes preparation of amide-linked intermediates used in synthetic route design for complex nitrogen-containing molecules.

5. Process Chemistry Intermediate

Fmoc-L-Leu-OSu can serve as a process chemistry intermediate for manufacturing of protected amino acid derivatives and activated acyl building blocks where reproducible coupling behavior is needed. The OSu ester form is designed for nucleophilic acyl substitution chemistry, and the Fmoc carbamate provides a standardized protection motif that can be removed under base conditions to reveal the amino group for subsequent steps. The single chiral center of L-leucine, maintained through the derivative, supports stereochemical consistency across batch syntheses and downstream purification planning. The resulting amide-linked intermediates and peptide building blocks can be employed in scalable fine chemical synthesis and in the preparation of defined chiral fragments for applied chemical production.

1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice